Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 17 Feb 2023
United States: The USPSTF advised against serological testing for the genital herpes simplex virus (HSV) in an advisory...
Read Full News(This Aug 27 story has been republished, with no changes to text.)
Barriers to blood donations from Black people in Canada are rooted in racism and restrictive policies.
After biochemical recurrence, hypofractionated RT may be no more effective than standard RT for disease control — and may have more late side effects.
Researchers followed 787 patients with brain tumors treated with laser therapy for up to 5 years.
Ibrutinib improves event-free survival in certain genetic subgroups of early-stage chronic lymphocytic leukemia but fails to extend overall survival.
1.
De-escalation Misses the Mark in Inflammatory Breast Cancer
2.
10-year study shows tomosynthesis improves breast cancer detection
3.
Adjunctive Cannabis Extract Improves Nausea-Vomiting Prevention in Cancer Patients
4.
Virtual Help Doubles Cancer Patients’ Smoking Quit Rate
5.
Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy
1.
Precision Era in Pediatric Oncology, from Genomic Breakthroughs to Lifelong Learning
2.
Revolutionizing Cancer Treatment with Trilaciclib: How a New Drug is Transforming Outcomes
3.
The Significance of APTT Blood Test Results for Detecting Coagulation Disorders
4.
Precision Oncology Using Tumor Evolutionary Trajectory Modeling
5.
Unlocking the Potential of Glofitamab: A Novel Treatment for Cancer
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC
2.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
3.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
4.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
5.
Diagnosis and Management in Hematology
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge